{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Probe-Based Near Infrared Autofluorescence for Parathyroid Identification"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly allocated to either the probe-based NIRAF group or the control group."
      },
      "Participants": {
        "score": 2,
        "evidence": "This randomised controlled trial enrolled patients undergoing parathyroidectomy for primary hyperparathyroidism at a single institution."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly allocated to either the probe-based NIRAF group or the control group."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the benefits of probe-based near infrared autofluorescence (NIRAF) for parathyroid identification."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the number of parathyroids identified with high confidence by the surgeon and resident, measured intraoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not feasible due to the nature of the intervention."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 160 patients were randomised, with 80 in each group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The senior surgeon's identification rate improved significantly in the probe group from 3.2 to 3.6 parathyroids per patient (p<0.001), and the junior surgeon's rate increased from 2.2 to 2.5 (p=0.001). Residents showed a significant increase from 0.9 to 2.9 parathyroids per patient (p<0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}